SNY
Sanofi ADR
NASDAQ: SNY · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$46.58
+1.19% today
Updated 2026-04-30
Market cap
$112.08B
P/E ratio
20.16
P/S ratio
2.40x
EPS (TTM)
$2.32
Dividend yield
8.67%
52W range
$43 – $53
Volume
3.5M
Sanofi ADR (SNY) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+20.6%
Last 4 quarters
Revenue YoY growth
+6.0%
Most recent quarter
EPS YoY growth
+8.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+2.1%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+3.8%
2025-10-24
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-23 | $1.10 | +4.9% | $46.90 | $46.78 | -0.3% |
| 2026-01-29 | $1.53 | +82.1% | $45.77 | $47.04 | +2.8% |
| 2025-10-24 | $1.69 | +4.3% | $49.52 | $51.41 | +3.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $1.05 | $1.10 | +4.9% | $11.24B | +6.0% |
| 2025-12-31 | $0.84 | $1.53 | +82.1% | $12.21B | +59.9% |
| 2025-09-30 | $1.62 | $1.69 | +4.3% | $13.17B | -7.0% |
| 2025-06-30 | $1.00 | $0.91 | -9.0% | $10.73B | -5.7% |
| 2025-03-31 | $0.95 | $1.02 | +7.4% | $10.61B | +9.0% |
| 2024-12-31 | $0.74 | $0.68 | -8.1% | $7.63B | -37.5% |
| 2024-09-30 | $1.38 | $1.54 | +11.6% | $14.16B | +11.5% |
| 2024-06-30 | $0.86 | $0.93 | +8.1% | $11.38B | +6.5% |
| 2024-03-31 | $0.94 | $0.97 | +3.2% | $9.73B | — |
| 2023-12-31 | $1.50 | $0.89 | -40.7% | $12.20B | — |
| 2023-09-30 | $2.27 | $2.77 | +22.0% | $12.70B | — |
| 2023-06-30 | $1.55 | $0.95 | -38.7% | $10.68B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $8.48 | $52.4B | +3.9% | 25 | high |
| 2027 (E) | $8.94 | $55.4B | +5.6% | 25 | high |
| 2028 (E) | $9.45 | $58.8B | +6.1% | 25 | medium |
| 2029 (E) | $9.98 | $62.3B | +6.0% | 25 | medium |
| 2030 (E) | $10.54 | $65.9B | +5.8% | 25 | low |
Frequently asked questions
Has Sanofi ADR beaten earnings estimates?
Sanofi ADR has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +20.6% over the last 4 quarters.
How does SNY stock react to earnings?
SNY stock has moved an average of +2.1% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Sanofi ADR's revenue growth rate?
Sanofi ADR reported year-over-year revenue growth of +6.0% in its most recent quarter, with EPS growing +8.0% year-over-year.
What is the expected EPS for SNY in 2026?
Analysts expect Sanofi ADR to report EPS of $8.48 for fiscal year 2026, on revenue of $52.4B, based on estimates from 25 analysts.